Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder' Aug 24, 2012 08:05AM
Needham & Company on Endo Pharmaceuticals (ENDP): Watson (WPI) Gains First Generic Lidoderm Approval; A Few Other Issues Too Aug 24, 2012 07:59AM
Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo Jul 20, 2012 08:31AM
Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); For A Few Pennies More, WPI Takes Big Time Price Increases Jun 29, 2012 08:20AM
Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Lidoderm Settlement A Mild Plus May 30, 2012 07:40AM


Apr 26, 2012 09:21AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Actavis Acquisition Big, But Easy Money Already Made
Mar 22, 2012 07:51AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Looking at Actavis
Jan 25, 2012 08:58AM Needham & Company on Watson Pharma (WPI); Shares Continue Prochieve Retreat Though Key Expected 2012/13 Growth Levers Appear Largely Unchanged
Jan 23, 2012 10:24AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Path to Near-Term PROCHIEVE Approval Appears Cloudy as Efficacy Fails to Meet FDA Threshold
Dec 21, 2011 03:44PM Notable 52-Week Highs and Lows of the Day 12/21: (CTAS) (CVS) (AMGN) High; (AMGN) (VECO) (CREE) Low
Dec 20, 2011 07:44AM Needham & Company on Watson Pharmaceuticals (WPI): Deal With Amgen Couples WPI’s Checkbook With Biotech Icon’s Development Prowess
Nov 2, 2011 08:18AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); Generics Again Carry the Day; Launch Calendar Suggests Continued Short-term EPS Upside
Sep 20, 2011 08:10AM Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); FDA Approves Amphastar’s Long Forgotten ANDA for Generic Lovenox
Jul 27, 2011 08:55AM Needham & Company maintains a 'Hold' on Watson Pharmaceuticals (WPI); Generic Business Strength Allows 2Q11 Results to “Beat” Expectations
Nov 30, 2010 01:28PM Needham & Company on Impax Labs (IPXL); Lawsuit Appears to Confirm That Generic Concerta Opportunity Remains A Real But Distant Star On Horizon
Apr 16, 2010 09:38AM Needham & Company Upgrades Watson Pharmaceuticals (WPI); FDA Comes Through Again with Approval of Generic Toprol XL
Mar 16, 2010 07:42AM Needham & Company Maintains an 'Underperform' on Watson Pharmaceuticals (WPI); Shares Already Discount Turnaround Dynamics
Jan 22, 2010 08:34AM Needham & Co Downgrades Watson Pharmaceuticals (WPI) to Underperform.
Sep 25, 2008 07:56AM Needham & Co Initiates Coverage on Watson Pharmaceuticals (WPI)